NCT00583258View on ClinicalTrials.gov

A Randomized Study of Whether Alfuzosin(Xatral) Helps in the Passage of Kidney Stones

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 31, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

October 31, 2009

Conditions
Kidney Stones
Interventions
DRUG

Alfuzosin (Xatral)

10 mg PO once a day

DRUG

Placebo Alfuzosin

10 mg PO once a day

Trial Locations (1)

M5B 1W8

St. Michael's Hospital, Toronto

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Unity Health Toronto

OTHER